Importantly, several reports indicate that SLs and, in particular S1P, can regulate ERM family protein activation in many cell types, including tumor cells, such as breast cancer and glioblastoma cells [142] as well as chondrogenic cells [143]. This evidence concerns the gene ETV5 and breast carcinoma.